Physician profile
Vinay Katukuri
NPI 1992860597
$10,036.66
in general payments reported to CMS, 2019-2025
19 companies · $2,489 in 2025
The $2,489 reported for 2025 was more than what 83% of Gastroenterology (Internal Medicine) providers received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $62.53 · 2021: $51.62 · 2022: $445 · 2023: $317 · 2024: $6,671 · 2025: $2,489.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $6,665 · Food and Beverage: $1,871 · Travel and Lodging: $941.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $6,665.00 |
| Food and Beverage | $1,871.16 |
| Travel and Lodging | $941.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Phathom Pharmaceuticals, INC. | $7,987.55 | 2023-2025 | Voquezna |
| Abbvie INC. | $1,095.55 | 2020-2025 | |
| Boston Scientific Corporation | $186.38 | 2024-2025 | General - Biliary Devices, Axios |
| Nestle Healthcare Nutrition INC. | $134.51 | 2022 | |
| Mallinckrodt Hospital Products INC. | $124.25 | 2025 | Terlivaz |
| Janssen Biotech, INC. | $100.64 | 2023-2025 | Simponi Aria, Stelara, Simponi |
| Endogastric Solutions, INC | $67.07 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $57.00 | 2023-2025 | Xifaxan |
| Olympus America INC. | $47.84 | 2020 | |
| Regeneron Healthcare Solutions, INC. | $36.29 | 2025 | Dupixent |
| Celgene Corporation | $28.56 | 2022 | |
| Ardelyx, INC. | $28.15 | 2025 | Ibsrela |
| Fresenius Kabi USA, LLC | $26.24 | 2024 | Idacio |
| Redhill Biopharma INC. | $23.62 | 2022 | |
| Pfizer INC. | $23.18 | 2025 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $19.94 | 2025 | Omvoh |
| Pentax of America, INC. | $18.29 | 2025 | Pentax Medical, Inspira, C2 Cryoballoon Focal Controller |
| Genzyme Corporation | $17.84 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $13.76 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vinay Katukuri listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.